Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.44
Delayed Data
As of Feb 05
 -0.04 / -1.61%
Today’s Change
1.63
Today|||52-Week Range
26.25
+20.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues491.0K538.0K1.0M1.2M
 
 
 
 
 
Cost of Goods Sold249.0K107.0K212.0K228.0K
 
 
 
 
 
Depreciation And Amortization47.0K41.0K41.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income195.0K390.0K755.0K931.0K
 
 
 
 
 
General Expenses5.1M5.1M5.6M6.3M
 
 
 
 
 
Research And Development2.4M1.6M1.2M1.9M
 
 
 
 
 
Total Operating Expenses5.4M5.2M5.9M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.7M-4.9M-5.3M
 
 
 
 
 
Extraordinary Credit451.0K34.0K0.00139.0K
 
 
 
 
Other Expenses-26.0K-11.0K-22.0K-31.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-4.6M-4.9M-5.2M
 
 
 
 
 
Income Taxes-8.0K-2.0K-6.0K-2.0K
 
 
 
 
 
Net Income-4.5M-4.6M-4.9M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M2.2M2.7M3.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M2.2M2.7M3.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.25-$2.25-$1.75-$1.75
 
 
 
 
 
EPS Diluted-$2.25-$2.25-$1.75-$1.75